Market Leadership DistillerSR is a recognized leader in AI-enabled literature review automation with over 260 major research organizations, including 80% of top pharmaceutical and medical device companies, highlighting significant trust and market presence that can be leveraged for upselling or expanding into related healthcare research sectors.

Continuous Innovation Recent product launches such as EU-MDR workflow templates, AI training modules, and advanced evidence management demonstrate a strong focus on enhancing functionality and regulatory compliance, creating opportunities to cross-sell new features and capture clients needing cutting-edge research tools.

Regulatory Compliance Focus Full support for important guidelines like PRISMA 2020 and the release of EU-MDR workflow templates indicate that DistillerSR is strategically positioned to serve organizations with strict regulatory requirements, making it attractive for clients aiming to streamline compliance workflows.

Strong Funding and Growth Funding of approximately $20 million from Thomvest Ventures and double-digit growth signal investor confidence and market traction, providing sales teams with confidence to target similar clients seeking innovative, scalable software solutions within the research and healthcare ecosystem.

Technological Advantage Utilizing advanced technology stacks including Kubernetes, cloud platforms, and a publicly accessible API, DistillerSR offers highly integratable and customizable solutions that appeal to organizations looking to modernize and automate their literature review processes.